Does the aldosterone: renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study

BACKGROUND: High blood pressure is an important determinant of cardiovascular disease risk. Treated hypertensives do not attain a risk level equivalent to normotensives. This may be a consequence of suboptimal blood pressure control to which indiscriminate use of antihypertensive drugs may contribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Parthasarathy, Hari K, Alhashmi, Khamis, McMahon, Alex D, Struthers, Allan D, Connell, John MC, McInnes, Gordon T, Ford, Ian, MacDonald, Thomas M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1877813/
https://www.ncbi.nlm.nih.gov/pubmed/17490489
http://dx.doi.org/10.1186/1471-2261-7-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1877813/
https://www.ncbi.nlm.nih.gov/pubmed/17490489
http://dx.doi.org/10.1186/1471-2261-7-14

Ejemplares similares